Αποτελέσματα Αναζήτησης
21 Οκτ 2019 · Since July 2018, >2 dozen specific ARB products have been recalled owing to the presence of potentially carcinogenic nitrosamine impurities in selected lots. As is the case with all U.S. drug recalls, the ARB recalls have been voluntary on the part of the companies involved.
- View Epub
PK Kp¬Xoa«, mimetypeapplication/epub+zipPK Kp¬X...
- View Epub
24 Σεπ 2019 · Over the past year, the FDA has recalled multiple blood pressure medications from several manufacturers after discovering potential carcinogens in some batches. It’s believed they became contaminated during the manufacturing process.
Stay informed on FDA updates and press announcements about recalls involving angiotensin II receptor blockers (ARBs) like valsartan and losartan. Discover key safety alerts, reasons for...
20 Αυγ 2020 · Between July 2018 and September 2019, the U.S. Food and Drug Administration (FDA) announced the recall of hundreds of lots of blood pressure drugs. The recall was prompted by the discovery of cancer-causing impurities in the medications.
All drug recalls are monitored by the Food and Drug Administration (FDA) and are included in the Enforcement Report once they are properly classified. The FDA will determine if a firm's removal or correction actions of a marked product meet the requirements to be considered a "recall".
10 Μαρ 2021 · Of the 25 mg tablets, lot numbers 148969, 148791, and 148991 have been recalled. Of the 50 mg tablets, lot number 148992 has been recalled. Bryant Ranch said it’s notifying customers affected...
24 Ιαν 2024 · In 2018, the FDA announced a recall of several blood pressure drugs containing valsartan because of contamination with a probable cancer-causing chemical.
